265 related articles for article (PubMed ID: 15956627)
1. Biotechnology products and university-based science.
Lempert P
JAMA; 2005 Jun; 293(23):2861-2; author reply 2863. PubMed ID: 15956627
[No Abstract] [Full Text] [Related]
2. Biotechnology products and university-based science.
Sobolski GK
JAMA; 2005 Jun; 293(23):2862; author reply 2863. PubMed ID: 15956629
[No Abstract] [Full Text] [Related]
3. Biotechnology products and university-based science.
Korn D; Heinig SJ
JAMA; 2005 Jun; 293(23):2862-3; author reply 2863. PubMed ID: 15956628
[No Abstract] [Full Text] [Related]
4. [Patent rights and the free research. The boundary between basic research and private sector is not longer razor-sharp].
Westerlund L
Lakartidningen; 2005 Sep 26-Oct 2; 102(39):2737. PubMed ID: 16245544
[No Abstract] [Full Text] [Related]
5. University-based science and biotechnology products: defining the boundaries of intellectual property.
Kesselheim AS; Avorn J
JAMA; 2005 Feb; 293(7):850-4. PubMed ID: 15713775
[TBL] [Abstract][Full Text] [Related]
6. Science and the law. Working through the patent problem.
Walsh JP; Cohen WM; Arora A
Science; 2003 Feb; 299(5609):1021. PubMed ID: 12586928
[No Abstract] [Full Text] [Related]
7. Patenting basic research: myths and realities.
Kirschenbaum SR
Nat Neurosci; 2002 Nov; 5 Suppl():1025-7. PubMed ID: 12403976
[No Abstract] [Full Text] [Related]
8. A modest proposal: toward improved access to biotechnology research tools by implementing a broad experimental use exception.
Hoffman DC
Cornell Law Rev; 2004 May; 89(4):993-1043. PubMed ID: 15174465
[No Abstract] [Full Text] [Related]
9. "Obvious to try": a proper patentability standard in the pharmaceutical arts?
Trask AV
Fordham Law Rev; 2008 Apr; 76(5):2625-68. PubMed ID: 18546581
[No Abstract] [Full Text] [Related]
10. In search of a compromised solution to the problem arising from patenting biomedical research tools.
Derzko NM
Santa Clara Comput High Technol Law J; 2004; 20(2):347-410. PubMed ID: 16493840
[No Abstract] [Full Text] [Related]
11. The MTA-rip it up and start again?
Ku K; Henderson J
Nat Biotechnol; 2007 Jul; 25(7):721-4. PubMed ID: 17621290
[No Abstract] [Full Text] [Related]
12. Protecting rights to early-stage technology.
Shuster MJ; Su H; Blaug S
Nat Biotechnol; 2003 Jun; 21(6):701-3. PubMed ID: 12776151
[No Abstract] [Full Text] [Related]
13. Bayh-Dole: if we knew then what we know now.
Boettiger S; Bennett AB
Nat Biotechnol; 2006 Mar; 24(3):320-3. PubMed ID: 16525405
[No Abstract] [Full Text] [Related]
14. Razing the tollbooths. A call for restricting patents on basic biomedical research.
Stix G
Sci Am; 2003 Apr; 288(4):37. PubMed ID: 12661312
[No Abstract] [Full Text] [Related]
15. Research interactions between industry and academia: a corporate perspective.
Citron P
Physiologist; 1996 Jun; 39(3):81, 90-2. PubMed ID: 16764116
[No Abstract] [Full Text] [Related]
16. Enforcing pharmaceutical and biotech patent rights in China.
Zhang YP; Deng MM
Nat Biotechnol; 2008 Nov; 26(11):1235-40. PubMed ID: 18997760
[No Abstract] [Full Text] [Related]
17. A guide to drug discovery. Protecting your inventions: the patent system.
Webber PM
Nat Rev Drug Discov; 2003 Oct; 2(10):823-30. PubMed ID: 14526385
[TBL] [Abstract][Full Text] [Related]
18. Intellectual property and biotechnology: the U.S. internal experience--Part II.
Brody B
Kennedy Inst Ethics J; 2006 Jun; 16(2):105-28. PubMed ID: 17036443
[TBL] [Abstract][Full Text] [Related]
19. Intellectual property and biotechnology: the U.S. internal experience--Part I.
Brody B
Kennedy Inst Ethics J; 2006 Mar; 16(1):1-37. PubMed ID: 16770885
[TBL] [Abstract][Full Text] [Related]
20. Much ado about gene patents: the role of foreseeability.
Gulliford MJ
Seton Hall Law Rev; 2004; 34(2):711-45. PubMed ID: 15115032
[No Abstract] [Full Text] [Related]
[Next] [New Search]